&w=3840&q=100)
In a first, UK reports West Nile virus in mosquitoes; experts blame it on climate change
In what is being seen a consequence of climate change, the West Nile virus has been detected in the United Kingdom for the first time. As temperatures are rising across the world, diseases are popping in places with no history of that disease. The West Nile virus in the UK is just one such example. read more
A vector control team vehicle displays a sign warning of West Nile Virus before the early morning spraying of a neighborhood due to increasing numbers of mosquitoes having tested positive for West Nile virus in San Diego, California, U.S. May 18, 2016. (Representative Photo, Credit: Reuters)
For the first time, the West Nile virus has been detected in the United Kingdom. Climate change is being considered as the culprit.
In a routine mosquito surveillance programme, the Animal and Plant Health Agency (APHA) found the West Nile virus in a batch of aedes vexans mosquitoes collected from marshlands on Idle river in Nottinghamshire. No case has been detected in the UK so far and experts say that the risk of an outbreak is very low.
STORY CONTINUES BELOW THIS AD
While the West Nile virus has been endemic to Africa and West Asia for decades, the climate change-induced warming up of Europe has brought the virus to the continent as well. The UK is the latest European country to report the virus.
The West Nile virus is primarily found in birds. Mosquitoes that bite birds get the virus and occasionally transfer it to humans with their bites. As much as 80 per cent of human infections cause no symptoms and severe infections are rare. In severe cases, encephalitis can occur and can lead to brain damage and even death. While the virus is not contagious among humans, it can spread from an infected person via blood transfusion, organ transplants, pregnancy, or breastfeeding.
Climate change brings West Nile virus to UK
The confirmation of the West Nile virus in the UK follows warnings that carriers of vector-borne diseases, such as dengue and yellow fever, are moving northwards from their traditional areas due to climate change.
Dr Arran Folly, an arbovirologist at the APHA and head of the surveillance programme that found the virus in the UK told Guardian that the discovery is 'part of a wider changing landscape where, in the wake of climate change, mosquito-borne diseases are expanding to new areas'.
The warming up of a place makes it likelier for the West Nile virus to grow. At 15*C, it takes many months for the virus to reach infectious level, which is much more than a mosquito's average lifespan. At 30*C, however, the same process can happen in two-three weeks, which is within a mosquito's average lifespan.
STORY CONTINUES BELOW THIS AD
In an article for The Conversation, Dr Paul Hunter noted that while the exact route of West Nile virus to the UK is not clear, it is believed that the virus may have arrived via migratory birds infected elsewhere.
So far, conditions ripe for a West Nile virus outbreak in the UK have not been reached but that could change if temperatures keep rising.
'For a local outbreak to occur, there would need to be a critical mass of infected birds and mosquitoes, with enough warm weather to sustain multiple cycles of transmission. So far, that hasn't happened in the UK. But climate change could alter the equation. With rising global temperatures and longer, hotter summers, the conditions that allow viruses such as West Nile to spread may become more common in the UK,' noted Hunter, a specialist in medical microbiology and virology.
As temperatures are rising across the world, diseases are being reported in places with no history of that disease. The West Nile virus in the UK is just one such example.
STORY CONTINUES BELOW THIS AD
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Birth control increases stroke risk - here's what women need to know
London: For millions of women, combined hormonal contraceptives are a part of their daily life - providing a convenient and effective option for preventing pregnancy and managing their menstrual cycle. But new findings are sounding the alarm on a serious, and often overlooked, risk: stroke . According to recent findings presented at the European Stroke Organisation Conference , combined oral hormonal contraceptives (which contains both oestrogen and progestogen) may significantly increase the chance of women experiencing a cryptogenic stroke. This is a sudden and serious type of stroke that occurs with no obvious cause. Surprisingly, in younger adults - particularly women - cryptogenic strokes make up approximately 40 per cent of all strokes. This suggests there may be sex-specific factors which contribute to this risk - such as hormonal contraception use. These recently-presented findings lend themselves to this theory. At this year's conference, researchers presented findings from the Secreto study. This is an international investigation that has been conducted into the causes of unexplained strokes in young people aged 18 to 49. The study enrolled 608 patients with cryptogenic ischaemic stroke from 13 different European countries. One of their most striking discoveries was that women who used combined oral contraceptives were three times more likely to experience a cryptogenic stroke compared to non-users. These results stood, even after researchers adjusted for other factors which may have contributed to stroke risk (such as obesity and history of migraines). It's well-documented that hormonal contraceptives, which contain both oestrogen and progestin, come with a small, increased risk of experiencing serious health events, including stroke - particularly ischaemic stroke, which occurs when blood flow to part of the brain is blocked. But a study published earlier this year, which tracked over two million women, found that combined hormonal contraceptives - including the pill, intrauterine devices (IUD), patches and vaginal rings, which all contain both synthetic oestrogen and progestogen - were linked to higher risks of both stroke and heart attack. The vaginal ring increased stroke risk by 2.4 times and 3.8 times for heart attack. The contraceptive patch was found to increase stroke risk by nearly 3.5 times. Interestingly, they also looked at a progestin-only contraceptive (the IUD) and found there was no increased risk for either heart attacks or strokes. Both of these recent findings suggest oestrogen may be the main driver of stroke risk. While absolute risk is still low - meaning fewer than 40 in every 100,000 women using a combined hormonal contraceptive will experience a stroke - the population-level impact is significant considering the number of women worldwide that use a combined hormonal contraceptive. Oestrogen and stroke risk Combined hormonal contraceptives contain synthetic versions of the sex hormones oestrogen (usually ethinylestradiol) and a progestin (the synthetic version of progestogen). Natural oestrogen in the body plays a role in promoting blood clotting, which is important for helping wounds heal and prevents excessive bleeding. But the synthetic oestrogen in contraceptives is more potent and delivered in higher, steady doses. It stimulates the liver to produce extra clotting proteins and reduces natural anticoagulants - tipping the balance toward easier clot formation. This effect, while helpful in stopping bleeding, can raise the risk of abnormal blood clots that can lead to conditions such as stroke. This risk may be even greater for people who smoke, experience migraines or have a genetic tendency to clot. If a clot forms in an artery that supplies the brain or breaks off and travels through the bloodstream to the brain, this can block blood flow - causing what's known as an ischaemic stroke. This is the most common type of stroke. Clots can also form in deep veins (such as those in the legs or around your organs). In addition to clotting, oestrogen may also slightly raise blood pressure and affect how blood vessels behave over time, which can further increase stroke risk. The effects of oestrogen on clotting may partly explain why the recent conference findings showed a link between combined contraceptive use and cryptogenic stroke risk. Cryptogenic stroke has no obvious cause, but is increasingly being linked to subtle, hidden risk factors - such as hormone-driven clotting. Understanding risk These numbers can sound alarming at first, but it's important to keep them in perspective. The absolute risk - meaning the actual number of people affected - is still low. For instance, researchers estimate that there may be one additional stroke per year for every 4,700 women using the combined pill. That sounds rare, and for most users, it is. But when you consider that millions of women use these contraceptives globally, even a small increase in risk can translate into a significant number of strokes at the population level. Which is relative to what is seen with the high number of cryptogenic strokes in young women. Despite the risks associated with combined hormonal contraceptives, many women continue to use them - either because they aren't fully informed of the risks or because the alternatives are either less effective, less accessible or come with their own burdens. Part of the reason this trade-off has become so normalised is the persistent under-funding and under-prioritisation of women's health research. Historically, medical research has focused disproportionately on men - with women either excluded from studies or treated as an afterthought. This has led to a limited understanding of how hormonal contraceptives affect female physiology beyond fertility control. As a result, the side-effects remain poorly understood, under-communicated and under-addressed. Women have a right to make informed decisions about their health and body. This starts with having access to accurate information about the real risks and benefits of every contraceptive option. It means understanding, for example, that while combined hormonal contraceptives do carry a small risk of blood clots and stroke, pregnancy and the weeks following childbirth come with an even higher risk of those same complications. This context is vital for making truly informed choices. No method of contraception is perfect. But when women are given the full picture, they can choose the method that best suits them. We also need more research that reflects the diversity and complexity of women's bodies - not just to improve safety, but to expand options and empower decisions. (The Conversation)
Time of India
8 hours ago
- Time of India
Astronomers discover the largest, oldest black hole jet ever
Astronomers have made a record discovery by observing the most massive and oldest black hole jet ever seen, which belongs to the quasar J1601+3102. The over 200,000 light-years-long jet, nearly twice as long as our Milky Way galaxy, is a one-of-a-kind glimpse into the early universe. The light from this quasar began its journey to Earth more than 12 billion years ago, and thus scientists can study the universe as it appeared when it was 1.2 billion years old, about 9% of its present age. The quasar J1601+3102 is powered by a massive black hole with a mass of approximately 450 million times the mass of our Sun. That's significant but modest by comparison to other quasars, whose black holes are billions of times more massive than the Sun. The finding overturns previous theories that only very large black holes were able to produce such gigantic jets, and it indicates that early universe black holes with a range of masses played an important role in the environment around them. All about this jet The observation was made possible through the collaborative power of some advanced telescopes: LOFAR (Low-Frequency Array): A system of European radio telescopes that first detected the jet. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Has Honda Done It Again? The New Honda CR-V is Finally Here. TheFactualist Undo Gemini Near-Infrared Spectrograph (GNIRS):Located in Hawaii, this facility allowed astronomers to measure the redshift of the quasar, how far away it is, and how old it is. Hobby-Eberly Telescope: Based in Texas, this telescope provided optical data to further elucidate the quasar and the jet. Implications for cosmic evolution The vast size of the jet would mean that even relatively small early-universe black holes would have been able to produce such energetic jets. They would have played a significant part in galaxy evolution by regulating the formation of stars and dispersing energy over enormous distances. The asymmetry of the jet would imply that environmental conditions may dictate the direction and power of such outflows. It is crucial to comprehend these dynamics to unravel the tangled interactions that determine galaxy formation. This discovery not only provides a glimpse of the activities of black holes in the primordial universe but also underlines the strength of modern radio astronomy. With the upgrading of technology, astronomers anticipate finding more similar phenomena, strengthening our knowledge of the universe's formative periods.
Indian Express
9 hours ago
- Indian Express
Birth control increases stroke risk – here's what women need to know
For millions of women, combined hormonal contraceptives are a part of their daily life – providing a convenient and effective option for preventing pregnancy and managing their menstrual cycle. But new findings are sounding the alarm on a serious, and often overlooked, risk: stroke. According to recent findings presented at the European Stroke Organisation Conference, combined oral hormonal contraceptives (which contains both oestrogen and progestogen) may significantly increase the chance of women experiencing a cryptogenic stroke. This is a sudden and serious type of stroke that occurs with no obvious cause. Surprisingly, in younger adults – particularly women – cryptogenic strokes make up approximately 40 per cent of all strokes. This suggests there may be sex-specific factors which contribute to this risk – such as hormonal contraception use. These recently-presented findings lend themselves to this theory. At this year's conference, researchers presented findings from the Secreto study. This is an international investigation that has been conducted into the causes of unexplained strokes in young people aged 18 to 49. The study enrolled 608 patients with cryptogenic ischaemic stroke from 13 different European countries. One of their most striking discoveries was that women who used combined oral contraceptives were three times more likely to experience a cryptogenic stroke compared to non-users. These results stood, even after researchers adjusted for other factors which may have contributed to stroke risk (such as obesity and history of migraines). It's well-documented that hormonal contraceptives, which contain both oestrogen and progestin, come with a small, increased risk of experiencing serious health events, including stroke – particularly ischaemic stroke, which occurs when blood flow to part of the brain is blocked. But a study published earlier this year, which tracked over two million women, found that combined hormonal contraceptives – including the pill, intrauterine devices (IUD), patches and vaginal rings, which all contain both synthetic oestrogen and progestogen – were linked to higher risks of both stroke and heart attack. The vaginal ring increased stroke risk by 2.4 times and 3.8 times for heart attack. The contraceptive patch was found to increase stroke risk by nearly 3.5 times. Interestingly, they also looked at a progestin-only contraceptive (the IUD) and found there was no increased risk for either heart attacks or strokes. Both of these recent findings suggest oestrogen may be the main driver of stroke risk. While absolute risk is still low – meaning fewer than 40 in every 100,000 women using a combined hormonal contraceptive will experience a stroke – the population-level impact is significant considering the number of women worldwide that use a combined hormonal contraceptive. Oestrogen and stroke risk Combined hormonal contraceptives contain synthetic versions of the sex hormones oestrogen (usually ethinylestradiol) and a progestin (the synthetic version of progestogen). Natural oestrogen in the body plays a role in promoting blood clotting, which is important for helping wounds heal and prevents excessive bleeding. But the synthetic oestrogen in contraceptives is more potent and delivered in higher, steady doses. It stimulates the liver to produce extra clotting proteins and reduces natural anticoagulants — tipping the balance toward easier clot formation. This effect, while helpful in stopping bleeding, can raise the risk of abnormal blood clots that can lead to conditions such as stroke. This risk may be even greater for people who smoke, experience migraines or have a genetic tendency to clot. If a clot forms in an artery that supplies the brain or breaks off and travels through the bloodstream to the brain, this can block blood flow – causing what's known as an ischaemic stroke. This is the most common type of stroke. Clots can also form in deep veins (such as those in the legs or around your organs). In addition to clotting, oestrogen may also slightly raise blood pressure and affect how blood vessels behave over time, which can further increase stroke risk. The effects of oestrogen on clotting may partly explain why the recent conference findings showed a link between combined contraceptive use and cryptogenic stroke risk. Cryptogenic stroke has no obvious cause, but is increasingly being linked to subtle, hidden risk factors – such as hormone-driven clotting. Understanding risk These numbers can sound alarming at first, but it's important to keep them in perspective. The absolute risk – meaning the actual number of people affected – is still low. For instance, researchers estimate that there may be one additional stroke per year for every 4,700 women using the combined pill. That sounds rare, and for most users, it is. But when you consider that millions of women use these contraceptives globally, even a small increase in risk can translate into a significant number of strokes at the population level. Which is relative to what is seen with the high number of cryptogenic strokes in young women. Despite the risks associated with combined hormonal contraceptives, many women continue to use them – either because they aren't fully informed of the risks or because the alternatives are either less effective, less accessible or come with their own burdens. Part of the reason this trade-off has become so normalised is the persistent under-funding and under-prioritisation of women's health research. Historically, medical research has focused disproportionately on men – with women either excluded from studies or treated as an afterthought. This has led to a limited understanding of how hormonal contraceptives affect female physiology beyond fertility control. As a result, the side-effects remain poorly understood, under-communicated and under-addressed. Women have a right to make informed decisions about their health and body. This starts with having access to accurate information about the real risks and benefits of every contraceptive option. It means understanding, for example, that while combined hormonal contraceptives do carry a small risk of blood clots and stroke, pregnancy and the weeks following childbirth come with an even higher risk of those same complications. This context is vital for making truly informed choices. No method of contraception is perfect. But when women are given the full picture, they can choose the method that best suits them. We also need more research that reflects the diversity and complexity of women's bodies – not just to improve safety, but to expand options and empower decisions.
